EPISODE · Jun 22, 2026 · 1 MIN
How Oral TKIs are Rewriting the Frontline and Pretreated Landscape in HER2-Mutant NSCLC
from TheBrief.Health · host TheBrief.Health
A new generation of oral HER2-targeted therapies is transforming advanced NSCLC care, delivering durable responses, brain metastasis control, and personalized treatment beyond traditional chemotherapy.
What this episode covers
A new generation of oral HER2-targeted therapies is transforming advanced NSCLC care, delivering durable responses, brain metastasis control, and personalized treatment beyond traditional chemotherapy.
NOW PLAYING
How Oral TKIs are Rewriting the Frontline and Pretreated Landscape in HER2-Mutant NSCLC
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m